Member Info for liquid1

Still in Auction

NYZ.F - Novacyt S.A.
Frankfurt - Frankfurt Delayed price. Currency in EUR
2.1000
+0.8100 (+62.79%)As of 8:36AM CET. Market open.

https://uk.finance.yahoo.com/quote/NYZ.F?.tsrc=applewf

CEO stated China FDA take a week or so on Thursday on CNN!!

NOVACYT
1.2900 (c) EUR
0.00%
THEORETICAL OPENING 1.9500

https://www.boursorama.com/bourse/forum/1rPALNOV/

The Department of Health said a "full infectious disease risk assessment" was done before Saturday's repatriation flight from Japan, adding that no-one who boarded the flight had displayed any symptoms of the virus.

------------------------------------

Should have used primierdesign, and had results even withour symptoms in 2 hours!
FFS, made in UK!! What's wrong with PHE & NHS??

Coronavirus: Four new UK cases among ship evacuees
8 minutes ago

https://www.bbc.co.uk/news/uk-51606368

Yes all the trolls are filtered from Thursday!

I just see a blank space!

So much nicer that the sh*te they regurgitate!

Nice

Ignore derampers! They are desperate!

1 kit has 150 tests!

144k has converted to orders!

Do the maths!

Size Images
532224 genesig Real-Time PCR Detection Kit for Coronavirus (Strain 2019-nCoV), Advanced
Fluorescent
Unlimited
10-100 copies 150 $1,507 1Kit

Great find!

144,000 orders x 1,500 = 260m

Before CFDA, FDA etc

https://mobile.twitter.com/jchatterleyCNN/status/1230529831181455361

https://youtu.be/qQViD89iPZU

Talking Novcyt

https://youtu.be/pi5QTMfaw84

Talking primerdesign test

https://www.medicaldevice-network.com/news/novacyt-fda-coronavirus-test/

7 FEBRUARY 2020 NEWS
Novacyt seeks Emergency Use Approval for coronavirus test






Image: The total number of confirmed coronavirus cases is 31,428 as of the end of 6 February. Credit: Gerd Altmann from Pixabay
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Biotech company Novacyt has applied to the US Food and Drug Administration for the Emergency Use Approval for its novel coronavirus (2019-nCoV) test, developed by its subsidiary Primerdesign.

The approval will enable the use of nCoV test for clinical diagnostic testing in laboratories temporarily.

The company claims that it is working with the FDA to indicate consistency and performance of the test for emergency use.

Novacyt is also in discussion with several NHS hospitals and Public Health England on the nCoV test.

The firm has already sold a limited number of tests to some hospitals so that they can validify.

Since the declaration of 2019-nCoV outbreak as a global emergency on 30 January 2020 by the WHO, the company claims that it has seen strong demand for its nCoVtest.

BREAKING: 2 dead, 54 infected after outbreak of Corona virus in Italy – Towns on lockdown
Paul Imanuelsen
By
Paul Imanuelsen
February 22, 2020

Italian Prime Minister Guiseppe Conte has said the government is considering “extraordinary measures” to combat the outbreak.

Now the governor of Veneto, Luca Zaia has said that university in Veneto will be closed next week due to the outbreak.

The deaths have prompted local authorities in Veneto and Lombardy to shut down schools, public transport, restaurants, shops and other public spaces to prevent the spread of coronavirus.

A total of over 50,000 people who live in the areas have been asked to stay at home

http://timesofsweden.com/2020/02/22/italy-coronavirus-update/

https://twitter.com/saraghavamian/status/1231245514668158976

Scary!!!

Novacyt begins vaccination tests against the coronavirus
The Franco-British biotechnology company Novacyt begins this week to test its vaccine against the Chinese coronavirus virus.

https://m.medwatch.dk/article/11946564

https://m.youtube.com/watch?feature=youtu.be&v=pi5QTMfaw84

BBC South Today - Primerdesign's Coronavirus kit designed to detect the latest outbreak (2019-nCoV).

https://mobile.twitter.com/PrimerdesignLtd/status/1231205866986262529?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

Watch all three interviews:

https://mobile.twitter.com/francisbrett/status/1226970357887832069?s=19

For those that missed it. Interview with Novacyt.